California regulators and a group of academic scientists are pressing EPA to substantially strengthen its approach to pending TSCA evaluations for a pair of phthalates, arguing that draft analyses for the chemicals underestimate health risks, fail to use the best available science and violate the agency’s just-finalized rule governing such reviews.